Atherosclerotic inflammatory switch

controls macrophage inflammatory response in atherosclerotic lesions

Written byTudor Toma
| 1 min read

Register for free to listen to this article
Listen with Speechify
0:00
1:00
Share

The progression of an atherosclerotic lesion involves lipid-laden macrophages (foam cells) migrating to vascular lesion sites, where they elicit a chronic inflammatory response. Despite some progress in understanding the molecular mechanisms of macrophage lipid loading, the mechanisms that control macrophage inflammatory status have been unclear. In the September 11 Sciencexpress, Chih-Hao Lee and colleagues at the Salk Institute for Biological Studies show that peroxisome proliferator–activated receptor δ(PPARδ) controls an inflammatory switch in the macrophages involved in the atherosclerotic lesion (Sciencexpress, DOI:10.1126/science.1087344, September 11, 2003).

Lee et al. examined peritoneal macrophages in mice lacking the low-density lipoprotein receptor (LDLR-/-) transplanted with PPARδ-/- bone marrow. They observed that deletion of PPARδ from foam cells increased the availability of inflammatory suppressors, which in turn reduced the atherosclerotic lesion by more than 50%.

"We propose an unconventional ligand-dependent transcriptional pathway in which PPARδ controls an inflammatory switch through its association and disassociation with transcriptional ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Meet the Author

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies